Novel Aspects of Hepatic Mitochondrial Amino Acid Metabolism
肝线粒体氨基酸代谢的新方面
基本信息
- 批准号:10170348
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-22 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAlanineAlanine TransaminaseAmino AcidsBloodCarbohydratesCarbonCarrier ProteinsCatabolismComplexCytosolDataDefectDevelopmentDiabetes MellitusEnzymesExerciseFastingGene DeletionGene ExpressionGluconeogenesisGlucoseGlycerolGoalsHepaticHepatocyteHomologous GeneHyperglycemiaImpairmentInner mitochondrial membraneInsulin ResistanceKnock-outKnowledgeLaboratoriesLiverLiver MitochondriaMediatingMetabolic PathwayMetabolismMitochondriaMitochondrial MatrixMolecularMusOrganismOrthologous GenePathway interactionsPharmacologic SubstancePhysiologicalPhysiological ProcessesPlayProcessProteinsPyruvatePyruvate Metabolism PathwayRegulationRoleScientific Advances and AccomplishmentsSkeletal MuscleSourceStarvationTechniquesTestingWorkYeastsactivating transcription factoractivating transcription factor 4amino acid metabolismclinical developmentdesigndiabeticendoplasmic reticulum stressglucose productionglycogenolysishepatic gluconeogenesisinsightmetabolic phenotypemitochondrial metabolismnovelnovel therapeuticsnutrient metabolismpyruvate carriertransamination
项目摘要
Project Summary/Abstract
The production of glucose by the liver is a vital physiological process. Hepatic glucose production plays
an important role in regulating normoglycemia during starvation, providing skeletal muscle with glucose
during exercise, and contributing to hyperglycemia of diabetes. Gluconeogenesis, the process of converting
the carbon in pyruvate, lactate, or amino acids into new glucose, plays an important role in glucose
production by the liver. Gluconeogenesis requires the transport of pyruvate or amino acids across the
impermeable inner mitochondrial membrane (IMM) and subsequent metabolism by enzymes exclusively
localized to the mitochondrial matrix. Recent work from the laboratory of the applicant has demonstrated an
important role for the mitochondrial pyruvate carrier (MPC) complex in gluconeogenesis from
pyruvate/lactate. However, these studies also suggested an important role for pyruvate-alanine cycling as a
compensatory mechanism when MPC activity was impaired. In addition, while amino acids like alanine are
believed to be an important substrate for gluconeogenesis, many details regarding their metabolism are
lacking. The significance of the proposed studies is that we will dissect the molecular mechanisms that
mediate these processes in fasting, exercise, and diabetes. We hypothesize that the transcription factor
ATF4 will regulate the expression of alanine transaminase 2 (ALT2) and that this enzyme will play an
important role in regulating alanine-stimulated gluconeogenesis in diabetic liver (Specific Aim 1). We also
hypothesize that that the effects of ALT2 deficiency on glucose production will be enhanced by concomitant
loss of MPC activity to disrupt gluconeogenesis from both alanine and pyruvate. (Specific Aim 2). We also
propose a third, exploratory Aim that has the potential for marked scientific advance. The transport of alanine
across the impermeable IMM by a carrier-mediated process is required for alanine to be used for
gluconeogenesis. However, the identity of the carrier that mediates this process has never been determined.
We hypothesize that the yeast Avt5 and its mammalian homolog Slc38a10 serve as the mitochondrial
alanine carrier and that these proteins are required for mitochondrial alanine metabolism (Specific Aim 3). We
believe that the proposed studies will provide marked scientific advance towards our understanding of hepatic
amino acid metabolism, which has been understudied to this point. In addition, these studies will provide
insight into the effects of these metabolic pathways on hepatic gluconeogenesis and could impact
pharmaceutical development of new drugs to treat diabetes.
项目摘要/摘要
肝脏的葡萄糖产生是一个重要的生理过程。肝葡萄糖生产
饥饿期间调节正常血糖的重要作用,为骨骼肌肉提供葡萄糖
在运动过程中,并导致糖尿病高血糖。糖异生,转化的过程
丙酮酸,乳酸或氨基酸中的碳进入新葡萄糖,在葡萄糖中起重要作用
肝脏的生产。糖异生需要丙酮酸或氨基酸在整个
不可渗透的内部线粒体膜(IMM)和随后的代谢仅由酶进行
位于线粒体基质中。申请人实验室的最新工作证明了
线粒体丙酮酸载体(MPC)复合物在糖异生中的重要作用
丙酮酸/乳酸。但是,这些研究还表明,丙酮酸 - 丙氨酸循环作为一种重要作用
MPC活性受损时的补偿机制。另外,氨基酸像丙氨酸
认为这是糖异生的重要底物,有关其代谢的许多细节是
缺乏。拟议的研究的意义在于,我们将剖析分子机制
在禁食,运动和糖尿病中调解这些过程。我们假设转录因子
ATF4将调节丙氨酸转氨酶2(ALT2)的表达,该酶将发挥作用
在调节丙氨酸刺激的糖尿病肝脏中糖异生中的重要作用(特定目标1)。我们也是
假设Alt2缺乏对葡萄糖产生的影响将通过同时增强
MPC活性的丧失,破坏丙氨酸和丙酮酸的糖异生。 (特定目标2)。我们也是
提出第三个探索性目标,具有明显的科学进步。丙氨酸的运输
在载体介导的过程中,丙氨酸需要使用载体介导的过程
糖异生。但是,从未确定介导该过程的载体的身份。
我们假设酵母AVT5及其哺乳动物同源性SLC38A10用作线粒体
丙氨酸载体,这些蛋白质是线粒体丙氨酸代谢所必需的(特定目标3)。我们
相信拟议的研究将为我们对肝的理解提供明显的科学进步
氨基酸代谢,至今已被研究了。此外,这些研究将提供
深入了解这些代谢途径对肝糖异生的影响,并可能影响
新药治疗糖尿病的药物开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brian N Finck其他文献
Brian N Finck的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Brian N Finck', 18)}}的其他基金
Phenomaster NG Mouse Metabolic Phenotyping System
Phenomaster NG 小鼠代谢表型系统
- 批准号:
10427654 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Novel insulin-sensitizing NASH/diabetes drugs.
新型胰岛素增敏 NASH/糖尿病药物。
- 批准号:
10218153 - 财政年份:2019
- 资助金额:
$ 38.13万 - 项目类别:
Novel insulin-sensitizing NASH/diabetes drugs.
新型胰岛素增敏 NASH/糖尿病药物。
- 批准号:
10096091 - 财政年份:2019
- 资助金额:
$ 38.13万 - 项目类别:
Novel insulin-sensitizing NASH/diabetes drugs.
新型胰岛素增敏 NASH/糖尿病药物。
- 批准号:
10471836 - 财政年份:2019
- 资助金额:
$ 38.13万 - 项目类别:
Novel Aspects of Hepatic Mitochondrial Amino Acid Metabolism
肝线粒体氨基酸代谢的新方面
- 批准号:
9789259 - 财政年份:2018
- 资助金额:
$ 38.13万 - 项目类别:
Novel Aspects of Hepatic Mitochondrial Amino Acid Metabolism
肝线粒体氨基酸代谢的新方面
- 批准号:
10406922 - 财政年份:2018
- 资助金额:
$ 38.13万 - 项目类别:
Targeting the mitochondrial pyruvate carrier to treat insulin resistance and nonalcoholic fatty liver disease
靶向线粒体丙酮酸载体治疗胰岛素抵抗和非酒精性脂肪肝
- 批准号:
10333375 - 财政年份:2015
- 资助金额:
$ 38.13万 - 项目类别:
Targeting the mitochondrial pyruvate carrier to treat insulin resistance and nonalcoholic fatty liver disease
靶向线粒体丙酮酸载体治疗胰岛素抵抗和非酒精性脂肪肝
- 批准号:
10533376 - 财政年份:2015
- 资助金额:
$ 38.13万 - 项目类别:
LIPIN 1 AND CARDIAC METABOLISM IN THE CONTEXT OF LIPID OVERLOAD
脂质超载背景下的 LIPIN 1 和心脏代谢
- 批准号:
8696255 - 财政年份:2014
- 资助金额:
$ 38.13万 - 项目类别:
LIPIN 1 AND CARDIAC METABOLISM IN THE CONTEXT OF LIPID OVERLOAD
脂质超载背景下的 LIPIN 1 和心脏代谢
- 批准号:
9304271 - 财政年份:2014
- 资助金额:
$ 38.13万 - 项目类别:
相似国自然基金
肠道微生态介导的苯丙氨酸代谢在三七皂苷抑制缺血性脑卒中继发性血栓形成中的作用机制研究
- 批准号:82304488
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
自由短肽微阵列用于高通量筛选二苯丙氨酸基抗菌肽
- 批准号:52303206
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于iPSC来源的类器官模型研究PHOX2B丙氨酸重复序列突变在肠脑神经系统中的致病效应及分子机制
- 批准号:
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:
L-苯丙氨酸通过lncRNA CHRF/miR-182-5p/BNIP3介导的线粒体自噬在人工甜味剂导致NAFLD中的机制研究
- 批准号:82370862
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
γ-干扰素介导SRSF3色氨酸-苯丙氨酸替代翻译在胃癌免疫微环境中的作用和机制研究
- 批准号:82303803
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Senescent hepatocytes mediate reprogramming of immune cells in acute liver failure
衰老肝细胞介导急性肝衰竭中免疫细胞的重编程
- 批准号:
10679938 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Perfluoroalkyl substances and non-alcoholic fatty liver disease in children: Leveraging magnetic resonance imaging to unravel potential mechanisms and exposure mixture effects
全氟烷基物质与儿童非酒精性脂肪肝:利用磁共振成像揭示潜在机制和暴露混合物效应
- 批准号:
10646759 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
The presentation and medical course of PCOS in adolescents across the United States
美国青少年多囊卵巢综合症的表现和医学过程
- 批准号:
10667067 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Development of pHLIP-phosphoantigen conjugates for lymphoma therapy
开发用于淋巴瘤治疗的 pHLIP-磷酸抗原缀合物
- 批准号:
10646988 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Uncovering the role of GPR75 as an activator of fatty acid transporters in non-alcoholic fatty liver disease (NAFLD)
揭示 GPR75 作为脂肪酸转运蛋白激活剂在非酒精性脂肪性肝病 (NAFLD) 中的作用
- 批准号:
10666762 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别: